What is it about?
The provisional tolerable intake value derived in this study is the first non-cancer risk assessment performed for the i.v. exposure of AgNP-containing medical devices.
Featured Image
Read the Original
This page is a summary of: Deriving a provisional tolerable intake for intravenous exposure to silver nanoparticles released from medical devices, Regulatory Toxicology and Pharmacology, January 2017, Elsevier,
DOI: 10.1016/j.yrtph.2017.01.007.
You can read the full text:
Contributors
The following have contributed to this page
